MethodHub Software has entered a partnership with Datafoundry to enhance its AI-driven Pharmacovigilance (PV) solutions for the pharmaceutical and biotech sectors. This collaboration, announced on July 6, 2026, aims to provide comprehensive, technology-based solutions that meet the increasing demands of regulatory compliance and the complexities of global clinical data.
The partnership will leverage MethodHub's expertise in PV operations and regulatory adherence, alongside Datafoundry's advanced AI/ML software-as-a-service solutions. This integration is intended to transform traditional, manual PV processes into streamlined, automated systems that are more efficient and compliant with international standards, such as those set by the FDA and EMA.
Datafoundry's AI solutions will enhance MethodHub's service offerings through three key platforms: Safety AI for automated safety case management, Signal AI for rapid signal detection and risk management, and Literature Monitor for automated literature surveillance. These tools will enable MethodHub to deliver improved accuracy and efficiency in its PV operations.
According to Mr. Ahobilam, CEO of MethodHub, the collaboration is pivotal for advancing patient safety and maintaining brand trust. By combining AI technologies with domain expertise, the partnership aims to create intelligent PV ecosystems that are ready for future challenges. Additionally, MethodHub will utilize its own AI-driven hiring platform, QuantumHire, to efficiently scale specialized PV talent for its clients.